NCT00271934View on ClinicalTrials.gov

Immune Ablation and Hematopoietic Stem Cell Support in Patients With Systemic Lupus Erythematosus: A Phase II Study

PHASE2CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

September 30, 2002

Primary Completion Date

November 30, 2007

Study Completion Date

April 30, 2012

Conditions
Systemic Lupus Erythematosus
Interventions
BIOLOGICAL

Immune ablation and hematopoietic stem cell support.

Autologous hematopoietic stem cell transplant

Trial Locations (1)

60611

Northwestern University, feinberg School of Medicine, Chicago

All Listed Sponsors
lead

Northwestern University

OTHER

NCT00271934 - Immune Ablation and Hematopoietic Stem Cell Support in Patients With Systemic Lupus Erythematosus: A Phase II Study | Biotech Hunter | Biotech Hunter